dc.creator | Ward L.S. | |
dc.date | 2010 | |
dc.date | 2015-06-26T12:34:46Z | |
dc.date | 2015-11-26T15:25:04Z | |
dc.date | 2015-06-26T12:34:46Z | |
dc.date | 2015-11-26T15:25:04Z | |
dc.date.accessioned | 2018-03-28T22:33:53Z | |
dc.date.available | 2018-03-28T22:33:53Z | |
dc.identifier | | |
dc.identifier | Arquivos Brasileiros De Endocrinologia E Metabologia. , v. 54, n. 5, p. 435 - 442, 2010. | |
dc.identifier | 42730 | |
dc.identifier | | |
dc.identifier | http://www.scopus.com/inward/record.url?eid=2-s2.0-77956791809&partnerID=40&md5=0c9cf4230c20d0ca37e93d6a0e02f182 | |
dc.identifier | http://www.repositorio.unicamp.br/handle/REPOSIP/90845 | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/90845 | |
dc.identifier | 2-s2.0-77956791809 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1260826 | |
dc.description | Although most hypothyroid patients do well with one single tablet of thyroxine daily, approximately 10% are dissatisfied and another important group of patients is difficult to control. We reviewed the most common causes for frequent-dose adjustment or high-dose requirement, including poor compliance with therapy and inadequate medication. Since these two causes have been ruled out, drug interaction and other concomitant diseases need to be investigated. Requirements of thyroxine increase in all conditions characterized by impaired gastric acid secretion. Proton-pump inhibitors, antacids and a long list of drugs may decrease thyroxine absorption. In addition, a series of diseases including celiac disease and chronic inflammatory intestinal diseases, as well as nutritional habits may be important in patient control. Finally, we mention the effects of a growing list of drugs and thyroid disruptors that may also affect thyroid hormone metabolism at many levels. Copyright© ABE&M todos os direitos reservados. | |
dc.description | 54 | |
dc.description | 5 | |
dc.description | 435 | |
dc.description | 442 | |
dc.description | Saravanan, P., Chau, W.F., Roberts, N., Vedhara, K., Greenwood, R., Dayan, C.M., Psychological well-being in patients on 'adequate' doses of l-thyroxine: Results of a large, controlled community-based questionnaire study (2002) Clin Endocrinol, 57 (5), pp. 577-585 | |
dc.description | Dayan, C.M., Panicker, V., Novel insights into thyroid hormones from the study of common genetic variation (2009) Nat Rev Endocrinol, 5 (4), pp. 211-218 | |
dc.description | Burnier, M., Medication adherence and persistence as the cornerstone of effective antihypertensive therapy (2006) Am J Hypertens, 19 (11), pp. 1190-1196 | |
dc.description | Friedman, O., McAlister, F.A., Yun, L., Campbell, N.R., Tu, K., Antihypertensive drug persistence and compliance among newly treated elderly hypertensives in Ontario (2010) Am J Med, 123 (2), pp. 173-181. , Canadian Hypertension Education Program Outcomes Research Taskforce | |
dc.description | Bagattoli, R.M., Vaisman, M., Lima, J.S., Ward, L.S., Estudo de adesão ao tratamento do hipotiroidismo (2000) Arq Bras Endocrinol Metab, 44 (6), pp. 483-487 | |
dc.description | Morris, J.C., How do you approach the problem of TSH elevation in a patient on high-dose thyroid hormone replacement? (2009) Clin Endocrinol, 70 (5), pp. 671-673 | |
dc.description | Santini, F., Pinchera, A., Marsili, A., Ceccarini, G., Castagna, M.G., Valeriano, R., Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases (2005) J Clin Endocrinol Metab, 90 (1), pp. 124-127 | |
dc.description | Asvold, B.O., Bjøro, T., Vatten, L.J., Association of serum TSH with high body mass differs between smokers and never-smokers (2009) J Clin Endocrinol Metab, 94 (12), pp. 5023-5027 | |
dc.description | Weiss, R.E., Brown, R.L., Doctor. Could it be my thyroid? (2008) Arch Intern Med, 168 (6), pp. 568-569 | |
dc.description | Kok, P., Roelfsema, F., Langendonk, J.G., Frölich, M., Burggraaf, J., Meinders, A.E., High circulating thyrotropin levels in obese women are reduced after body weight loss induced by caloric restriction (2005) J Clin Endocrinol Metab, 90 (8), pp. 4659-4653 | |
dc.description | Reinehr, T., de Sousa, G., Andler, W., Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids (2006) J Clin Endocrinol Metab, 91 (8), pp. 3088-3091 | |
dc.description | Onur, S., Haas, V., Bosy-Westphal, A., Hauer, M., Paul, T., Nutzinger, D., Klein, H., L-tri-iodothyronine is a major determinant of resting energy expenditure in underweight patients with anorexia nervosa and during weight gain (2005) Eur J Endocrinol, 152 (2), pp. 179-184 | |
dc.description | Knudsen, N., Bülow, I., Laurberg, P., Ovesen, L., Perrild, H., Jørgensen, T., Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population (2005) J Clin Endocrinol Metab, 90 (7), pp. 4019-4024 | |
dc.description | Jonklaas, J., Sex and age differences in levothyroxine dosage requirement (2010) Endocr Pract, 16 (1), pp. 71-79 | |
dc.description | Sawin, C.T., Herman, T., Molitch, M.E., London, M.H., Kramer, S.M., Aging and the thyroid. Decreased requirement for thyroid hormone in older hypothyroid patients (1983) Am J Med, 75 (2), pp. 206-209 | |
dc.description | Joint statement on the U.S. Food and Drug Administration's decision regarding bioequivalence of levothyroxine sodium (2004) Thyroid, 14 (7), p. 486. , American Thyroid Association | |
dc.description | Endocrine Society | |
dc.description | American Association of Clinical Endocrinologists | |
dc.description | Hennessey, J.V., Malabanan, A.O., Haugen, B.R., Levy, E.G., Adverse Event Reporting in Patients Treated with Levothyroxine: Results of the Pharmacovigilance Task Force Survey of the American Thyroid Association, American Association of Clinical Endocrinologists and The Endocrine Society (2010) Endocr Pract, 11, pp. 1-41. , Feb, [Epub ahead of print] | |
dc.description | Read, D.G., Hays, M.T., Hershman, J.M., Absorption of oral thyroxine in hypothyroid and normal man (1970) J Clin Endocrinol Metab, 30 (6), pp. 798-799 | |
dc.description | Benvenga, S., Bartolone, L., Squadrito, S., lo Giudice, F., Trimarchi, F., Delayed intestinal absorption of levothyroxine (1995) Thyroid, 5 (4), pp. 249-253 | |
dc.description | Read, D.G., Hays, M.T., Hershman, J.M., Absorption of oral thyroxine in hypothyroid and normal man (1970) J Clin Endocrinol Metab, 30 (6), pp. 798-799 | |
dc.description | Centanni, M., Gargano, L., Canettieri, G., Viceconti, N., Franchi, A., Fave, G.D., Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis (2006) N Engl J Med, 354 (17), pp. 1787-1795 | |
dc.description | Wenzel, K.W., Kirschsieper, H.E., Aspects of the absorption of oral L-thyroxine in normal man (1977) Metabolism, 26 (1), pp. 1-8 | |
dc.description | Yao, X., Forte, J.G., Cell biology of acid secretion by the parietal cell (2003) Annu Rev Physiol, 65, pp. 103-131 | |
dc.description | Hennemann, G., Docter, R., Friesema, E.C., de Jong, M., Krenning, E.P., Visser, T.J., Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability (2001) Endocr Rev, 22, pp. 451-476 | |
dc.description | Centanni, M., Robbins, J., Role of sodium in thyroid hormone uptake by rat skeletal muscle (1987) J Clin Invest, 80, pp. 1068-1072 | |
dc.description | Annibale, B., Marignani, M., Azzoni, C., D'Ambra, G., Caruana, P., D'Adda, T., Atrophic body gastritis: Distinct features associated with Helicobacter pylori infection (1997) Helicobacter, 2, pp. 57-64 | |
dc.description | Centanni, M., Marignani, M., Gargano, L., Corleto, V.D., Casini, A., Fave, G.D., Atrophic body gastritis in patients with autoimmune thyroid disease: An underdiagnosed association (1999) Arch Intern Med, 159, pp. 1726-1730 | |
dc.description | Kuipers, E.J., Uyterlinde, A.M., Peña, A.S., Roosendaal, R., Pals, G., Nelis, G.F., Long-term sequelae of Helicobacter pylori gastritis (1995) Lancet, 345, pp. 1525-1528 | |
dc.description | Sachs, G., Shin, J.M., Munson, K., Vagin, O., Lambrecht, N., Scott, D.R., Review: The control of gastric acid and Helicobacter pylori eradication (2000) Aliment Pharmacol Ther, 14, pp. 1383-1401 | |
dc.description | Yao, X., Forte, J.G., Cell biology of acid secretion by the parietal cell (2003) Annu Rev Physiol, 65, pp. 103-131 | |
dc.description | Lahner, E., Annibale, B., Fave, G.D., Systematic review: Helicobacter pylori infection and impaired drug absorption (2009) Aliment Pharmacol Ther, 29 (4), pp. 379-386 | |
dc.description | Ananthakrishnan, S., Braverman, L.E., Levin, R.M., Magnani, B., Pearce, E.N., The effect of famotidine, esomeprazole, and ezetimibe on levothyroxine absorption (2008) Thyroid, 18 (5), pp. 493-498 | |
dc.description | Singh, N., Weisler, S.L., Hershman, J.M., The acute effect of calcium carbonate on the intestinal absorption of levothyroxine (2001) Thyroid, 11 (10), pp. 976-971 | |
dc.description | Collin, P., Kaukinen, K., Välimäki, M., Salmi, J., Endocrinological disorders and celiac disease (2002) Endocr Rev, 23, pp. 464-483 | |
dc.description | Boelaert, K., Newby, P.R., Simmonds, M.J., Holder, R.L., Carr-Smith, J.D., Heward, J.M., Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease (2010) Am J Med, 123 (2), pp. 183-183 | |
dc.description | Surks, M.I., Ortiz, E., Daniels, G.H., Sawin, C.T., Col, N.F., Cobin, R.H., Subclinical thyroid disease. Scientific review and guidelines for diagnosis and management (2004) J Am Med Assoc, 291, pp. 228-238 | |
dc.description | McDermott, J.H., Coss, A., Walsh, C.H., Celiac disease presenting as resistant hypothyroidism (2005) Thyroid, 15 (4), pp. 386-388 | |
dc.description | Padwal, R., Brocks, D., Sharma, A.M., A systematic review of drug absorption following bariatric surgery and its theoretical implications (2010) Obes Rev, 11, pp. 41-50 | |
dc.description | Seppel, T., Rose, F., Schlaghecke, R., Chronic intestinal giardiasis with isolated levothyroxine malabsorption as reason for severe hypothyroidism - implications for localization of thyroid hormone absorption in the gut (1996) Exp Clin Endocrinol Diabetes, 104 (2), pp. 180-182 | |
dc.description | Muñoz-Torres, M., Varsavsky, M., Alonso, G., Lactose intolerance revealed by severe resistance to treatment with levothyroxine (2006) Thyroid, 16 (11), pp. 1171-1173 | |
dc.description | Pantos, C., Mourouzis, I., Xinaris, C., Cokkinos, D.V., Thyroid hormone and myocardial ischaemia (2008) J Steroid Biochem Mol Biol, 109 (3-5), pp. 314-322 | |
dc.description | Moruzzi, P., Doria, E., Agostoni, P.G., Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy (1996) Am J Med, 101 (5), pp. 461-467 | |
dc.description | Goarin, J.P., Cohen, S., Riou, B., Jacquens, Y., Guesde, R., le Bret, F., The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors (1996) Anesth Analg, 83 (1), pp. 41-47 | |
dc.description | Cooper, D.K., Novitzky, D., Wicomb, W.N., Basker, M., Rosendale, J.D., Kauffman, H.M., A review of studies relating to thyroid hormone therapy in brain-dead organ donors (2009) Front Biosci, 14, pp. 3750-3770 | |
dc.description | Mullis-Jansson, S.L., Argenziano, M., Corwin, S., Homma, S., Weinberg, A.D., Williams, M., A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery (1999) J Thorac Cardiovasc Surg, 117 (6), pp. 1128-1134 | |
dc.description | Novitzky, D., Cooper, D.K., Swanepoel, A., Inotropic effect of triiodothyronine (T3) in low cardiac output following cardioplegic arrest and cardiopulmonary bypass: An initial experience in patients undergoing open heart surgery (1989) Eur J Cardiothorac Surg, 3 (2), pp. 140-145 | |
dc.description | Henderson, K.K., Danzi, S., Paul, J.T., Leya, G., Klein, I., Samarel, A.M., Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure (2009) Circ Heart Fail, 2 (3), pp. 243-252 | |
dc.description | Brent, G.A., Hershman, J.M., Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration (1986) J Clin Endocrinol Metab, 63 (1), pp. 1-8 | |
dc.description | Sandek, A., Rauchhaus, M., Anker, S.D., von Haehling, S., The emerging role of the gut in chronic heart failure (2008) Curr Opin Clin Nutr Metab Care, 11 (5), pp. 632-639 | |
dc.description | Benvenga, S., Bartolone, L., Pappalardo, M.A., Russo, A., Lapa, D., Giorgianni, G., Altered intestinal absorption of L-thyroxine caused by coffee (2008) Thyroid, 18 (3), pp. 293-301 | |
dc.description | Chiu, A.C., Sherman, S.I., Effects of pharmacological fiber supplements on levothyroxine absorption (1998) Thyroid, 8 (8), pp. 667-671 | |
dc.description | Lilja, J.J., Laitinen, K., Neuvonen, P.J., Effects of grapefruit juice on the absorption of levothyroxine (2005) Br J Clin Pharmacol, 60 (3), pp. 337-341 | |
dc.description | Eskes, S.A., Wiersinga, W.M., Amiodarone and thyroid (2009) Best Pract Res Clin Endocrinol Metab, 23 (6), pp. 735-751 | |
dc.description | Cohen-Lehman, J., Dahl, P., Danzi, S., Klein, I., Effects of amiodarone therapy on thyroid function (2010) Nat Rev Endocrinol, 6 (1), pp. 34-41 | |
dc.description | Silva, J.R., Guariento, M.E., Fernandes, G.A., Maciel, R.M.B., Ward, L.S., Impact of long-term administration of amiodarone on the thyroid function of Chagas' disease patients (2004) Thyroid, 14 (5), pp. 373-379 | |
dc.description | Cappelli, C., Rotondi, M., Pirola, I., Agosti, B., Gandossi, E., Valentini, U., TSH-lowering effect of metformin in type 2 diabetic patients: Differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients (2009) Diabetes Care, 32 (9), pp. 1589-1590 | |
dc.description | Patrick, L., Thyroid disruption: Mechanism and clinical implications in human health (2009) Altern Med Rev, 14 (4), pp. 326-346 | |
dc.description | Uzma, N., Salar, B.M., Kumar, B.S., Aziz, N., David, M.A., Reddy, V.D., Impact of organic solvents and environmental pollutants on the physiological function in petrol filling workers (2008) Int J Environ Res Public Health, 5 (3), pp. 139-146 | |
dc.language | pt | |
dc.publisher | | |
dc.relation | Arquivos Brasileiros de Endocrinologia e Metabologia | |
dc.rights | aberto | |
dc.source | Scopus | |
dc.title | The Difficult Patient: Drug Interaction And The Influence Of Concomitant Diseases On The Treatment Of Hypothyroidism [o Paciente Difícil: Interação Entre Drogas E Influência De Doenças Concomitantes No Tratamento Do Hipotiroidismo] | |
dc.type | Artículos de revistas | |